The experimental validation focused on the expression of the cross-talk genes CYP1B1, CHPT1, and SERPING1 in in vitro models of T2DM-TB comorbidity as well as their impact on inflammatory responses and immune regulation. The gene discussed is CHPT1; the disease is tuberculosis.